Abstract
“Nutrigenomics” refers to the ability of nutrients to alter gene expression. Insulin secreting β-cells exhibit genomic and molecular changes that enhance their function when acutely exposed to physiological concentrations of glucose and fatty acids. However, chronic exposure, such as occurs in the hyperlipidemic, hyperglycemic state of obesity/ prediabetes can exert deleterious effects on β-cell function through alteration of gene expression. The genomic underpinnings of so-called glucolipotoxicity on the β-cell and its relationship to development of type 2 diabetes will be discussed in this review article. For example, free fatty acids influence β-cell gene expression by direct interaction with transcription factors such as peroxisome proliferator-activated receptors. Glucose responsive genes include the insulin gene as well as genes involved in β-cell survival and other functions. In addition, obesity is now recognized as a condition of chronic, low-level inflammation. The adipose tissue secretes multiple circulating hormones termed adipokines, and the relationship between these and the β-cell has been termed adipotoxicity. The influence of adipokines on regulation of insulin secretion and β-cell survival will be reviewed.
Keywords: Insulin, β-cell, glucolipotoxicity, adipotoxicity, nutrigenomics
Current Genomics
Title: Nutrigenomics, β-Cell Function and Type 2 Diabetes
Volume: 8 Issue: 1
Author(s): R. Nino-Fong, T. M. Collins and C. B. Chan
Affiliation:
Keywords: Insulin, β-cell, glucolipotoxicity, adipotoxicity, nutrigenomics
Abstract: “Nutrigenomics” refers to the ability of nutrients to alter gene expression. Insulin secreting β-cells exhibit genomic and molecular changes that enhance their function when acutely exposed to physiological concentrations of glucose and fatty acids. However, chronic exposure, such as occurs in the hyperlipidemic, hyperglycemic state of obesity/ prediabetes can exert deleterious effects on β-cell function through alteration of gene expression. The genomic underpinnings of so-called glucolipotoxicity on the β-cell and its relationship to development of type 2 diabetes will be discussed in this review article. For example, free fatty acids influence β-cell gene expression by direct interaction with transcription factors such as peroxisome proliferator-activated receptors. Glucose responsive genes include the insulin gene as well as genes involved in β-cell survival and other functions. In addition, obesity is now recognized as a condition of chronic, low-level inflammation. The adipose tissue secretes multiple circulating hormones termed adipokines, and the relationship between these and the β-cell has been termed adipotoxicity. The influence of adipokines on regulation of insulin secretion and β-cell survival will be reviewed.
Export Options
About this article
Cite this article as:
Nino-Fong R., Collins M. T. and Chan B. C., Nutrigenomics, β-Cell Function and Type 2 Diabetes, Current Genomics 2007; 8 (1) . https://dx.doi.org/10.2174/138920207780076947
DOI https://dx.doi.org/10.2174/138920207780076947 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
From CHD Susceptibility Genes to New Therapeutics
Current Pharmacogenomics The Role of Fibroblast Growth Factor 21 (FGF21) on Energy Balance, Glucose and Lipid Metabolism
Current Diabetes Reviews Editorial [Hot Topic: Nitric Oxide and Hydrogen Sulfide - Contribution of Gaseous Messengers to the Cardiovascular Control (Guest Editor: Sona Cacanyiova)]
Current Pharmaceutical Biotechnology Editorial [Hot topic: New Developments in the Treatment and Prevention of Vascular Disease - Part 1 (Executive Editors: N. Katsiki, V.G. Athyros and D.P. Mikhailidis)]
Current Pharmaceutical Design Dynamics of Telomere Length in Different Age Groups in a Latvian Population
Current Aging Science Nucleoside Transporter Proteins
Current Vascular Pharmacology Dipeptidyl-peptidase 4 Inhibition: Linking Metabolic Control to Cardiovascular Protection
Current Pharmaceutical Design Metabolic Obesity: The Paradox Between Visceral and Subcutaneous Fat
Current Diabetes Reviews Cashew Gum A Versatile Hydrophyllic Polymer: A Review
Current Drug Therapy Tetrahydrobiopterin Biosynthesis, Utilization and Pharmacological Effects
Current Drug Metabolism Drugs Used to Treat Parkinsons Disease, Present Status and Future Directions
CNS & Neurological Disorders - Drug Targets Immunological Aspects of the Prostate Gland and Related Diseases
Current Immunology Reviews (Discontinued) Nano- and Biotechnological Approaches in Current and Future Generation of Cardiovascular Stents
Current Nanoscience Vaccination Against High Blood Pressure
Current Pharmaceutical Design Status of Acetylcholinesterase and Butyrylcholinesterase in Alzheimer's Disease and Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Pleiotropic Effects of Glucagon-like Peptide-1 (GLP-1)-Based Therapies on Vascular Complications in Diabetes
Current Pharmaceutical Design Paring Down Obesity and Metabolic Disease by Targeting Inflammation and Oxidative Stress
Current Neurovascular Research Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Risk Models and Scores of Cardiovascular Disease in Patients with Diabetes Mellitus
Current Pharmaceutical Design Combining Diffusion-Weighted Imaging Patterns with ABCD2 Score Predicts Stroke Risk after Transient Ischemic Attack
Current Neurovascular Research